Silicon Kinetics

Silicon Kinetics is a life science technology company that developed advanced label-free biomolecular interaction analysis systems. The company's flagship platform, SKi Pro, utilizes proprietary Nanopore Optical Interferometry (NOI) to monitor molecular binding events in real-time with high sensitivity. This technology is particularly valuable in drug discovery for characterizing protein-protein and protein-small molecule interactions, including fragment-based screening. In 2021, the company's assets and technology were acquired by Sartorius, a leading international partner of the biopharmaceutical industry. The acquisition allowed Sartorius to expand its bioanalytical portfolio with Silicon Kinetics' unique optical sensing capabilities.